Effect of bupivacaine lozenges on oral mucositis pain: a randomized controlled multicenter phase II study

INTRODUCTION: A nonblinded parallel-group randomized controlled study investigated the efficacy and tolerability of repeated administration of a bupivacaine lozenge (25 mg) as pain management for oral mucositis pain in head and neck cancer patients as add-on to standard systemic pain management. OBJ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pain Rep
Main Authors: Mogensen, Stine, Treldal, Charlotte, Kristensen, Claus A., Bentzen, Jens, Lawson-Smith, Louise, Petersen, Janne, Andersen, Ove
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer 2017
Assuntos:
Cancer and Palliative
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5777682/
https://ncbi.nlm.nih.gov/pubmed/29392234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PR9.0000000000000619
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados